GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.060
-0.030 (-1.44%)
At close: Nov 25, 2025, 4:00 PM EST
2.010
-0.050 (-2.43%)
Pre-market: Nov 26, 2025, 6:03 AM EST

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
772---
Market Cap Growth
162.79%325.43%----
Enterprise Value
33-2---
Last Close Price
2.0614.08595.52---
PB Ratio
3.381.846.72---
P/TBV Ratio
3.381.846.72---
Debt / Equity Ratio
0.040.030.05-0.41-0.74-0.62
Quick Ratio
1.473.070.670.010.020.07
Current Ratio
1.703.431.090.160.020.07
Return on Equity (ROE)
-397.84%-382.52%----
Return on Assets (ROA)
-137.52%-118.39%-416.93%-465.68%-226.54%-
Return on Capital (ROIC)
-240.01%-232.68%----
Return on Capital Employed (ROCE)
-556.90%-200.70%-4300.00%139.00%22.80%30.30%
Earnings Yield
-195.38%-110.90%-749.46%---
FCF Yield
-136.84%-116.36%-517.27%---
Buyback Yield / Dilution
-2263.41%----2.26%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q